Outreach Signals
Publishing Details
Contact & Outreach
About This Podcast
Explore Statistics
Recent Episodes
Solving the PFIC Mystery: Genetic Testing and Diagnosis in Adults
Think PFIC is only a pediatric disease? Think again. Progressive Familial Intrahepatic Cholestasis (PFIC) was long considered a condition exclusive to children. However, breakthroughs in genomic…
New Frontiers in Esophagogastric Cancer with Dr. Yelena Janjigian
The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses how perioperative chemoimmunotherapy and precision biomarkers…
HER2-Mutant NSCLC Update: Expanded Approval of Zongertinib With Beth Sandy, MSN, CRNP, FAPO
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3health.com/course-information/nsclc-advances The FDA’s…
The Future of Hemophilia: New Data, New Guidance, New Outcomes with Robert F. Sidonio, Jr., MD, MSc
Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest breakthroughs in research and clinical…
Advancing Care in Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 2
Treatment for systemic mastocytosis (SM) has evolved fast—are your management strategies keeping up? Join Dr. Castells as she dives into the latest advances in SM therapy, including how and when to…
Unlocking Systemic Mastocytosis: Expert Strategies with Dr. Mariana Castells - Module 1
Systemic mastocytosis (SM) can hide in plain sight—are you catching it when it counts? In this case‑driven conversation, Dr. Mariana Castells breaks down the real-world diagnostic journey of SM,…
Rethinking Schizophrenia: Multidimensional Symptoms and Modern Management
Schizophrenia is far more than hallucinations and delusions. In this Faculty Follow-Up, Christoph U. Correll, MD—Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at…
Closing the Gaps in NET Diagnosis and Treatment: A Conversation With Aman Chauhan, MD
Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of…
Breaking Barriers in Biliary Tract Cancer: Innovations, Trials, and Advocacy
Biliary tract cancers, including cholangiocarcinoma, are among the most complex and aggressive malignancies in oncology. In this episode, we are joined by Melinda Bachini, Chief Patient Officer at…
Ulcerative Colitis Advances: Latest Research and Clinical Trials with Benjamin Cohen, MD
The management of ulcerative colitis (UC) has moved far beyond simple symptom control, evolving into a sophisticated era of precision medicine fueled by an ever-expanding therapeutic armamentarium.…
Psoriatic Arthritis: Early Diagnosis, Emerging Therapies, and Expert Insights
This Multidisciplinary Task Force explores strategies for increasing early intervention and optimizing management of psoriatic arthritis. It features perspectives from a panel of experts discussing…
Additional Advances in ALS Research and Clinical Trials With Richard S. Bedlack, MD, PhD, MS
The ALS treatment landscape is shifting faster than ever, with emerging clinical trial data and advances in gene‑targeted therapies reshaping how healthcare professionals think about disease…
EXPIRING SOON! Schizophrenia Update: Module 4: Applying the Latest Therapeutic Advances to Patient-Centered Care
Effective schizophrenia management requires a holistic, patient-centered approach tailored to the individual’s unique needs. This final module focuses on integrating evidence-based strategies with…
EXPIRING SOON! Schizophrenia Update: Module 3: Emerging Treatments for Cognitive Symptoms
Cognitive impairment is a core feature of schizophrenia that contributes heavily to long-term disability. In Module 3, discover current and emerging pharmacologic treatments designed to target…
EXPIRING SOON! Schizophrenia Update: Module 2: Advances in Long-Acting Injectables
Adherence to oral antipsychotics is frequently disrupted by complex dosing schedules and side effects. This module examines the clinical benefits of long-acting injectables (LAIs), including steadier…
EXPIRING SOON! Schizophrenia Update: Module 1: Understanding the Evolving Treatment Landscape
Schizophrenia remains a complex challenge that significantly impacts life expectancy and daily functioning. While dopamine-blocking agents have long been the standard of care, their limitations often…
Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 2
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced…
Additional Advances in Melanoma Research and Clinical Trials With Michael A. Davies, MD, PhD + Module 1
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced…
Navigating HER2-Mutant NSCLC Pathology and Management: A Webinar Preview With Helena A. Yu, MD, and Maria Arcila, MD
Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the…
Discovering Systemic Mastocytosis in Practice: A Webinar Preview With Lauren M. Madigan, MD
Join Lauren M. Madigan, MD, Associate Professor of Dermatology at the University of Utah, for a sneak peek at our upcoming live webinar, Beyond the Skin: Uncovering Systemic Mastocytosis (SM) in…
Frequently Asked Questions
i3 Health Podcast has published 75 episodes since December 2022, covering topics in Science.
i3 Health Podcast is currently moderate with new episodes every 2 weeks. Average episode length is 17m.
Sign up on Grep.FM to access contact details for i3 Health Podcast, including email and social media links.
